Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

Reports of fidaxomicin treatment for patients with multiple recurrent Clostridium difficile infections ([mrCDI] ie, more than 2 CDI episodes) indicate symptomatic response to this agent, but 50% have subsequent mrCDI episodes. In an effort to improve outcomes in patients with mrCDI we used novel reg...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Open Forum Infect Dis
Hoofdauteurs: Soriano, Melinda M., Danziger, Larry H., Gerding, Dale N., Johnson, Stuart
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2014
Onderwerpen:
Major Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281782/
https://ncbi.nlm.nih.gov/pubmed/25734139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofu069
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items